Anatoly Slepenkin
About
In The Last Decade
Anatoly Slepenkin
30 papers receiving 877 citations
Peers
Comparison fields: 5 of 98
- Immunology 359
- Microbiology 293
- Molecular Biology 242
- Epidemiology 227
- Infectious Diseases 136
Countries citing papers authored by Anatoly Slepenkin
This map shows the geographic impact of Anatoly Slepenkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anatoly Slepenkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anatoly Slepenkin more than expected).
Fields of papers citing papers by Anatoly Slepenkin
This network shows the impact of papers produced by Anatoly Slepenkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anatoly Slepenkin. The network helps show where Anatoly Slepenkin may publish in the future.
Co-authorship network of co-authors of Anatoly Slepenkin
This figure shows the co-authorship network connecting the top 25 collaborators of Anatoly Slepenkin. A scholar is included among the top collaborators of Anatoly Slepenkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anatoly Slepenkin. Anatoly Slepenkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 4 | |
| 3 | 11 | |
| 4 | 10 | |
| 5 | 29 | |
| 6 | 6 | |
| 7 | 31 | |
| 8 | 25 | |
| 9 | 40 | |
| 10 | 24 | |
| 11 | 33 | |
| 12 | 121 | |
| 13 | 39 | |
| 14 | 83 | |
| 15 | 80 | |
| 16 | 33 | |
| 17 | 10 | |
| 18 | 57 | |
| 19 | [Anaerobic degradation of biphenyl by the facultative anaerobic strain Citrobacter freundi BS2211]. | 13 |
| 20 | Biotransformation of adamantane and alkyladamantanes | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.